Ocuphire Pharma
zeta scores study and fellow eye | Ocuphire Pharma
Company
Deck Type
Deck date
January 2023
Slide
11 of 31
Related slides by other companies
MindMed
Investor Presentation
November 2024
for gad phase study designs voyage panorama | MindMed
Bausch+Lomb
Results
May 2023
building a global dynamic dry eye disease platform dry eye total revenue for | Bausch+Lomb
MindMed
Investor Presentation
December 2024
for phase study design design | MindMed
Theravance Biopharma
Investor Conference
November 2022
study disposition | Theravance Biopharma
Other recent decks by Ocuphire Pharma
See all presentations (10 decks)
Investor Presentation
November 2023
Investor Presentation
August 2023
Investor Presentation
May 2023
Results
October 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights